- Home
- IMNN vs GP Comparison
IMNN vs GP Comparison
Compare IMNN & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- GP
- Stock Information
- Founded
- IMNN 1982
- GP 2010
- Country
- IMNN United States
- GP Canada
- Employees
- IMNN N/A
- GP N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- GP Construction/Ag Equipment/Trucks
- Sector
- IMNN Health Care
- GP Consumer Discretionary
- Exchange
- IMNN Nasdaq
- GP Nasdaq
- Market Cap
- IMNN 12.1M
- GP 12.7M
- IPO Year
- IMNN 1985
- GP 2020
- Fundamental
- Price
- IMNN $1.46
- GP $0.43
- Analyst Decision
- IMNN Buy
- GP Strong Buy
- Analyst Count
- IMNN 2
- GP 2
- Target Price
- IMNN $14.00
- GP $2.33
- AVG Volume (30 Days)
- IMNN 31.5M
- GP 68.8K
- Earning Date
- IMNN 05-12-2025
- GP 06-27-2025
- Dividend Yield
- IMNN N/A
- GP N/A
- EPS Growth
- IMNN N/A
- GP N/A
- EPS
- IMNN N/A
- GP N/A
- Revenue
- IMNN N/A
- GP $20,656,035.00
- Revenue This Year
- IMNN N/A
- GP N/A
- Revenue Next Year
- IMNN N/A
- GP $94.25
- P/E Ratio
- IMNN N/A
- GP N/A
- Revenue Growth
- IMNN N/A
- GP N/A
- 52 Week Low
- IMNN $0.37
- GP $0.41
- 52 Week High
- IMNN $3.65
- GP $1.90
- Technical
- Relative Strength Index (RSI)
- IMNN 52.73
- GP 43.81
- Support Level
- IMNN $0.85
- GP $0.42
- Resistance Level
- IMNN $3.16
- GP $0.45
- Average True Range (ATR)
- IMNN 0.52
- GP 0.03
- MACD
- IMNN 0.03
- GP -0.00
- Stochastic Oscillator
- IMNN 39.07
- GP 14.29
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.